RecruitingNCT07305753
CanCan Body Composition Study
Sponsor
Pennington Biomedical Research Center
Enrollment
40 participants
Start Date
Oct 15, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The aim of this study is to develop a dataset with reference body composition measurements using criterion methods. This dataset will be used to develop new protocols to study patients with cancer. Obtaining measurements of sodium bromide (NaBr), deuterium dilution (D2O), and D3-Creatine in a stratified sample of adults will determine the accuracy (and precision) of the available devices for ECW, TBW, and skeletal muscle mass measurements.
Eligibility
Min Age: 20 YearsMax Age: 90 Years
Inclusion Criteria6
- Being either male or female
- Being an adult \>20 - \<40 or \>70 years of age.
- Having a body weight of less than 440 pounds
- Being willing to comply with the study procedures
- Not having a chronic illness (e.g., diabetes, cancer, etc.)
- Must be willing to have biospecimens and imaging stored for research use
Exclusion Criteria7
- Being pregnant, attempting to become pregnant, or breastfeeding
- Having medical implants such as a pacemaker or metal joint replacements
- Having had a mastectomy, breast reduction, or breast implants
- Having hair that cannot fit in a swim cap
- Having a body weight greater than 440 pounds
- Taking medications that alter the body's fluid compartments (ex: diuretics)
- Not willing to have biospecimens and imaging stored for future research use.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07305753
Related Trials
Effects of Food Intake Sequence on Substrate Utilisation and Endurance Performance
NCT075039901 location
A Study to Assess the Bioequivalence of Trastuzumab Via Different Subcutaneous Delivery Platforms in Healthy Male Participants
NCT072147664 locations
A Study to Learn How the Body Processes the Study Medicine Called Vepdegestrant in People With Loss of Liver Function
NCT072319914 locations
A Phase I, Open-label, Crossover Study Comparing the Relative Bioavailability of a Fixed-Dose Combination of Laroprovstat/Rosuvastatin vs Their Single Therapy Products in Healthy Adults
NCT073166082 locations
Portable VR-based Chromatic Pupilloperimeter for Diagnosis and Monitoring of Traumatic Brain Injury
NCT074749871 location